Automated external defibrillators overview
Automated external defibrillators are tools for restoring a healthy heart rhythm. The main drivers boosting the automated electronic defibrillator market growth are the rising incidence of cardiac disease, the rising elderly population, technical advancements in the industry, and rising investments from market players.
Automated defibrillators are machines that monitor cardiac rhythm automatically, and if a problem is detected by providing shock, it brings the heart rhythm back to normal. AEDs are used in various areas (including hospitals and airports) and play a significant role in improving the opportunities for life-saving defibrillation because of their small size and ease of use.
The external defibrillators market was value at $1.71 billion in 2021 and is anticipate growing to $3.64 billion by 2030. Throughout the anticipated period, North America utterly dominated the market.
- The rising incidence of cardiovascular diseases (CVDs) is expecting to boost the automated external defibrillator market during the forecast period. The World Health Organization (WHO) repored that cardiovascular diseases are the main cause of death worldwide, asserting an estimated 17.9 million lives each year. Heart attacks and strokes account for more than four out of every five CVD deaths, and one-third of the deaths occur in people under the age of 70.
- Increasing defibrillator training and awareness programs are looking forward to boost the growth of the global automated external defibrillator market during the forecast period. For instance, in March 2021, GAA launched a defibrillator awareness program. The program enables clubs to raise funds for new AEDs linked to the internet via the mobile phone network. This means that automated external defibrillators will check and notify users via email if there is a problem.
The external defibrillator market will be hamper by a lack of awareness and early corrective measures for sudden cardiac arrest. For instance, many other medical conditions or lifestyle choices can put people at high risk of heart diseases, including diabetes, obesity and overweight, unhealthy diet, lack of physical activity, and high alcohol consumption.
The global aging population is expect to create lucrative markets for players in the global external defibrillator market. The aging population is associated with progressive deterioration in the structure and function of the heart, and it serves as a catalyst for the development of chronic diseases.
- By type of analysis, the industry is divide into semi-automatic and fully automate defibrillators. Fully automatic devices are predict to generate more than 80% of market revenue by 2030. The ease of use of fully automatic AEDs over semi-automatic devices is driving the growth of this category. Furthermore, fully automatic devices are deliberate to eliminate the long delays related with pressing the shock button in semi-automatic device.
- By end-user, the industry is divide into hospitals and clinics, specialize cardiovascular disease treatment centers, and ambulatory surgery centers. Hospitals will dominate the global external defibrillator market, owing to the high demand for ICD implantation in hospitals, which is driving this segment’s growth. In contrast, implementing defibrillators in workplaces is looking forward to boost industry growth prospects.
- By region, the industry is segment into North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America. North America was the biggest market for AEDs, accounting for roughly 60% of the global market in 2021. It is primarily due to improved healthcare infrastructure, the presence of players, and an increase in the region’s senior population. Furthermore, the rising prevalence of CVDs and the increasing number of AED installations have aided market growth in North America.
Acquisitions and product launches are among the most important strategic developments in the market for automated external defibrillators.
Major players in the market are:
- Koninklijke Philips NV
- Nihon Kohden Corporation
- Schiller AG
- CU Medical Systems Inc.
- Mediana Co. Ltd
- Stryker Corporation
Koninklijke Philips N.V. completed the acquisition of BioTelemetry Inc., a provider of remote cardiac diagnostics and monitoring solutions based in the United States, in February 2021. This acquisition would transform care delivery along the health continuum with integrated solutions.
Koninklijke Philips N.V. launched its remote monitoring and defibrillation solution (Tempus ALS) for pre-hospital settings in the United States in July 2020. It is a complete system that broadens the pre-hospital scope of care.